Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer (Q44085049)

29 November 2017

title

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer (English)

1 reference

29 November 2017

Mevlude Inanc

1

1 reference

29 November 2017

Metin Ozkan

2

1 reference

29 November 2017

Halit Karaca

3

1 reference

29 November 2017

Veli Berk

4

1 reference

29 November 2017

Oktay Bozkurt

5

1 reference

29 November 2017

Ayse Ocak Duran

6

1 reference

29 November 2017

Ersin Ozaslan

7

1 reference

29 November 2017

Hulya Akgun

8

1 reference

29 November 2017

Fatos Tekelioglu

9

1 reference

29 November 2017

Ferhan Elmali

10

1 reference

29 November 2017

publication date

11 December 2013

1 reference

29 November 2017

1 reference

29 November 2017

volume

31

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

801

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Relevance of PTEN loss in brain metastasis formation in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Predictors of early distant metastasis in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Distant metastasis in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Clinical significance of morphologic characteristics in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Gene expression profiling of breast cell lines identifies potential new basal markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0801-7

Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin

21 January 2018

1 reference

12 December 2020

Clinical significance of CK5/6 and PTEN protein expression in patients with bilateral breast carcinoma

1 reference

12 December 2020

Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast

1 reference

12 December 2020

Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features

1 reference

12 December 2020

Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer

1 reference

12 December 2020

Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer

1 reference

12 December 2020

Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?

1 reference

12 December 2020

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

1 reference

12 December 2020

Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group

1 reference

12 December 2020

10.1007/S12032-013-0801-7

Identifiers

DOI

1 reference

29 November 2017

1 reference